MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGFβI During Skeletal Muscle Development in Pigs

PLoS ONE - United States
doi 10.1371/journal.pone.0119396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeting the PI3K/AKT/mTOR Signaling Axis in Children With Hematologic Malignancies

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2012English

MicroRNA-21 Promotes Glioma Cell Proliferation and Inhibits Senescence and Apoptosis by Targeting SPRY1 via the PTEN/PI3K/AKT Signaling Pathway

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2018English

MicroRNA‑21‑5p Targeting PDCD4 Suppresses Apoptosis via Regulating the PI3K/AKT/FOXO1 Signaling Pathway in Tongue Squamous Cell Carcinoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports
Multidisciplinary
2017English

Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

MicroRNA-145 Inhibits Growth of Laryngeal Squamous Cell Carcinoma by Targeting the PI3K/Akt Signaling Pathway

Cancer Management and Research
Oncology
2019English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Trim32 Reduces PI3K–Akt–FoxO Signaling in Muscle Atrophy by Promoting Plakoglobin–PI3K Dissociation

Journal of Cell Biology
MedicineCell Biology
2014English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy